Cell Culture Market for Media, Sera and Reagents (2011-2016)
By: marketsandmarkets.com
Publishing Date:
July 2012
Report Code:
BT 1763
Cell culture is a process in which cells are grown under controlled conditions. Growth in the biopharmaceuticals market is the major driver for growth in the cell culture market. It is the most integral part of biopharmaceutical development, bioprocessing, and manufacturing.
The choice of cells depends on various technical and economic aspects. E. coli, Bacillus subtitlus, and yeast are the most preferred bacteria as they are easier to grow, independent, and have metabolic capabilities. On the other hand, animal cells are fragile, larger than microorganisms and difficult to grow. Another important driver is the development of vaccines; influenza vaccines have been previously developed with the help of egg-based technology. However, due its labor-intensive approach, this has been replaced with cell culture. A growth in this market will subsequently drive the market for cell culture.
Market players are making significant investments in Asia due to a favorable scenario for stem cell research. The cell culture market is fairly consolidated; major players being AMRESCO Inc., Analytical Biological Services Inc., Athena Enzyme Services, Atlanta Biologicals Inc., BD Biosciences, BIOCHROM AG, Bioreclamation Inc., Cell Essentials Inc., CellGenix Technologie Transfer GmbH, ClonTech Laboratories Inc., EMD Millipore, Gemini Bio-Products, Irvine Scientific, Invitria, and others. Invitrogen, based in U.S., is the largest player globally by its GIBCO brand.
We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.
Please visit http://www.marketsandmarkets.com/custom-research.asp
to specify your custom Research Requirement
